Market Tracker

07/30 11:11am ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

13.86
Real-Time Quote
 +0.16 / +1.17%
Today’s Change
8.57
Today|||52-Week Range
20.29
+48.39%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close13.70
Today’s open13.90
Day’s range13.74 - 14.16
Volume92,830
Average volume (3 months)524,206
Market cap$1.0B
Dividend yield--
Data as of 10:55am ET, 07/30/2014

Growth & Valuation

Earnings growth (last year)-962.50%
Earnings growth (this year)-15.04%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-94.51%
P/E ratioNM
Price/Sales214.35
Price/Book7.66

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...+0.03+0.64%
TSROTESARO Inc+0.19+0.65%
INSYInsys Therapeutics I...+0.24+0.80%
LGNDLigand Pharmaceutica...+0.13+0.25%
Data as of 11:08am ET, 07/30/2014

Financials

Last reporting dateJuly 30, 2014
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$2.9M
Annual profit (last year)-$46.1M
Net profit margin-1,578.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin C. Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts